External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASRS 2025
Roche and Genentech at

ASRS 2025

July 30 - August 02
California, USA / Virtual (Hybrid)
asrs.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:00 PM
Duration 10mins Long Beach Convention Center
Machine Learning–Based 3D Volumetric Analysis of Pigment Epithelial Detachment Reduction With Faricimab▼ vs Aflibercept in TENAYA/LUCERNE
Yoshihiro Yonekawa, Lanzetta P, Albrecht T, Harrell E, Hibar D, Lu H, Patel S, Yang M, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Faricimab▼ Real-World Data Support Clinical Trial Data in Patients With Treatment-Naïve nAMD: Results From TENAYA/LUCERNE and FARETINA/FARWIDE
Sara Haug, Avery R, Souied E, Bonine N, Dayal P, Kotecha A, Margaron P, Yang M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Predictors of Extended Treatment Intervals in Patients With DME Treated With Faricimab▼ in the Phase 3 YOSEMITE/RHINE Trials
Michael Klufas, Gerendas B, Ambresin A, Arevalo J F, Gibson K, Sim D, Yang M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Global Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Treatment-Naïve Patients With nAMD or DME: The VOYAGER Study
Aboobaker S, Schmitz-Valckenberg S, Bailey C, Chaikitmongkol V, Chaudhary V, Chi GC, Downey A, Finger RP, Koh A HC, Ishida S, Lövestam-Adrian M, Parravano M, Luna Pinto JD, Sheth V, Shi B, Souied EH, Uschner D, Guymer R
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Outcomes of Faricimab▼ in nAMD From the UK: 18-Month Results From the FARWIDE-nAMD Study
Praveen Patel, Varma D, Talks J, De Salvo G, De Silva S, Gale R, McKibbin M, Chi G, James N, Downey A, Dodds M, Dayal P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Outcomes of Faricimab▼ in DME From the UK: 1-Year Results From the FARWIDE-DME Study
Ian Pearce, Peto T, Sivaprasad S, Reynolds R, Bailey C, Downey L,Kiire C, Chi G, James N, Downey A, Dodds M, Dayal P
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With RVO: A BALATON/COMINO Post Hoc Analysis
Carl Danzig, Bhatt H, Dagincourt N, Pereira L P, Schweitzer J, Thommen J
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Survey on Physician Preferences and Dosing Schedules for Anti-VEGF Therapies in the Treatment of nAMD
Shilpa Gulati, Ko S, Bonine N, Coak E, Mascia D, Li K
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Fluctuations in Pigment Epithelial Detachment Thickness in the Archway Phase 3 Trial of the PDS
Malik D, Brodie F, Graff J, Lai T, Ruiz Medrano J, Priglinger S, Blotner, Gordon A, Holekamp N, Prager, A Heinrich D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Impact of the Optimization of Surgical Procedure on the Incidence of Endophthalmitis and Associated Outcomes of Patients in PDS Trials
Chang M, Chaudhry N, Campochiaro P, Pieramici D, Regillo C, Bobbala A, Gune S, Jaycock P, Kardatzke D, Prager A, Singh N
Ophthalmology | Diabetic Macular Edema - Diabetic Retinopathy - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Mitigating Conjunctival Erosions in Patients Treated With the PDS: Surgical Management and Clinical Outcomes
Suan E, Klufas M, Regillo C, Awh C, Gordon A, Blotner S, Prager A, Singh N, Utley S, Gune S
Ophthalmology | Diabetic Macular Edema - Diabetic Retinopathy - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Clinical Impact of Continuous Drug Delivery via the PDS in Retinal Diseases
Arevalo JF, Graff J, Campochiaro P, Chakravarthy U, Emanuelli A, Gill M, Rachitskaya A, Wirthlin R, Blotner S, Gune S, Singh N
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Treatment Patterns and Ocular Morbidity in Patients With Uveitic Macular Edema Secondary to Noninfectious Uveitis in the United States
Uchiyama E, Chen L, Dayal P, Pal N, Stoilov I, Mesquida M, Haskova Z, Steeples L
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:51 PM
Duration 3mins Long Beach Convention Center
Volumetric Analysis of Hard Exudates on Optical Coherence Tomography: Biomarker Results of Faricimab▼ vs Aflibercept From Phase 3 YOSEMITE/RHINE
Murtaza Adam, Vujosevic S, Pollreisz A, Dinah C, Goldberg R, Ip M, Rahimy E, Amador M, Bachmeier I, Gibson K, Maunz A, O'Leary O, Uschner D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:54 PM
Duration 3mins Long Beach Convention Center
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Andres Emanuelli, Amador M, Brown J, Coney J, Cunningham M, Gonzalez L, Huddleston S,Scott A, Milunovich S, Yang M, Lu X-Y
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:57 PM
Duration 3mins Long Beach Convention Center
Update on Faricimab▼ for DME: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Veeral Sheth, Arshad M. Khanani, Cheryl Jones, Kara Gibson, Timothy Y. Y. Lai, Ian Pearce, Patricio Schlottmann, Dawn A. Sim
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:09 PM
Duration 3mins Long Beach Convention Center
Comparability of Diabetic Retinopathy Severity Evaluation on Gold Standard vs Ultrawide Field Images in YOSEMITE/RHINE Phase 3 Studies
Blodi B, Domalpally A, Tang Y, Willis J, Gibson K, Khanani A, Wykoff C, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:38 PM
Duration 3mins Long Beach Convention Center
Impact of PDS in Study Eyes vs Intravitreal Injections in Fellow Eyes in Pagoda Trial Patients With Bilateral Diabetic Macular Edema (DME)
Graff J, Eichenbaum, D, Wirthlin R, Yi-Ting Hsieh, Jason Hsu, Patricia Udaondo, Heinrich D, Gune S, Blotner S, Jones M, Schimpl A, Santhanankrishnan A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:37 AM
Duration 60mins California, USA
Quantitative Ultra-Widefield Fluorescein Angiography for the Assessment of Novel Biomarkers of Vascular Stability With Faricimab▼ in YOSEMITE/RHINE
Karen Matar, Justis Ehlers, Indurkar A, Della Vecchia L, Amine R, Mamone J, Tang A, Gibson K, Dagincourt N, Mar F, Amador M, Warter A, Sim D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins California, USA
Zifibancimig Administered via Intravitreal Injection and the Port Delivery Platform in Patients With nAMD: Rationale and Design of the Burgundy Study
Wolfe J, Haug S, Dhoot D, Kim J, Kwong M, Callaway N, Orduna J, Steiert B, Wollenhaupt M, Wentzel C
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:35 PM
Duration 3mins Long Beach Convention Center
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Ben Bakall, Tan C, Gallego-Pinazo R, Koh A, Pitcher J, Yang M, Patel S, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:44 PM
Duration 3mins Long Beach Convention Center
Indirect Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in DME and nAMD
Nik London, Keane P, Holekamp N, Leng T,Siedlecki J, Mar F, Gibson K, Margaron P, Buehrer C, Tabano D
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:47 PM
Duration 3mins Long Beach Convention Center
Five Year Outcomes in nAMD Patients Enrolled in the Archway Study and Treated With the PDS
Kitchens J, Andrea-Thanei G, Blotner S, Gune S, Rabena M, Singh N
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.